How many institutional investors hold BTAI?

2 tracked institutional investors disclosed a position in BTAI (BIOXCEL THERAPEUTICS INC) in their most recent 13F filing.

Who is the largest institutional holder of BTAI?

Izzy Englander, Millennium Management, holds the largest disclosed position in BTAI, valued at $3M.

Where does this BTAI ownership data come from?

SEC Form 13F-HR filings, accessed via EDGAR. 13F filings are disclosed quarterly with a 45-day reporting delay and cover U.S.-listed long equity positions only. This is not investment advice.

BTAI — BIOXCEL THERAPEUTICS INC

Name: BIOXCEL THERAPEUTICS INC (BTAI) — Institutional Ownership
Creator: InvestorLens
License: https://www.sec.gov/about/website-policies

Public company

For educational research only.InvestorLens analyzes public regulatory filings (SEC EDGAR, STOCK Act PTRs) that may be delayed by 45 days or more. Information shown is historical and is not financial, legal, or tax advice, nor a recommendation or solicitation to buy or sell any security. Always do your own research.

InvestorLens aggregates public filing data to show which tracked investors reported holdings in this stock. Dollar values represent reported position values, not market capitalization, and may be delayed up to 45 days. Not a recommendation.

Sourced from SEC EDGAR public filings

About BIOXCEL THERAPEUTICS INC (BTAI)

BIOXCEL THERAPEUTICS INC (BTAI) appears in the most recent 13F filings of 2 tracked institutional investors. The largest disclosed position is held by Izzy Englander (Millennium Management), valued at $3M. Across recent filings, tracked investors recorded 4 new positions, 0 increased, 0 reduced, and 0 exited. All data sourced from SEC 13F filings.

Smart Money Consensus™

Based on recent institutional activity in BTAI

100

/100

Strong Institutional Accumulation

Added / Increased4

Reduced0

Exited0

BearishBullish

Crowded Trade Score™

How many top investors track BTAI

/100

Undiscovered

2investors

Only 2 tracked investors report this position.

UndiscoveredCrowded

151015+

BTAI Ownership Composition

How BIOXCEL THERAPEUTICS INC is held across tracked investor types, based on reported 13F positions.

Dominant Type

Other

89% of tracked value

Institutions

tracked investors

Total Reported

$2.9M

combined 13F value

Other88.9%
Hedge Funds11.1%

Other(1)

88.9%

Hedge Funds(1)

11.1%

Tracked investors reporting BTAI

Investor	Firm	Shares	Market value	% of portfolio	As of
Izzy Englander	Millennium Management	1.9M	$2.6M	0.00%	Mar 31, 2026
Howard Marks	Oaktree Capital Management	241.2K	$323.2K	0.00%	Mar 31, 2026

Izzy EnglanderMar 31, 2026
Millennium Management
Shares
1.9M
Value
$2.6M
% Portfolio
0.00%
Howard MarksMar 31, 2026
Oaktree Capital Management
Shares
241.2K
Value
$323.2K
% Portfolio
0.00%

Recent activity

Investor	Action	Δ %	Current value	Filing date
Howard Marks	New	—	$323.2K	May 19, 2026
Howard Marks	New	—	$323.2K	May 20, 2026
Izzy Englander	New	—	$2.9M	Feb 17, 2026
Izzy Englander	New	—	$2.6M	May 15, 2026

Howard Marks
New
$323.2KMay 19, 2026
Howard Marks
New
$323.2KMay 20, 2026
Izzy Englander
New
$2.9MFeb 17, 2026
Izzy Englander
New
$2.6MMay 15, 2026

Frequently asked questions

How many institutional investors hold BTAI?: 2 tracked institutional investors disclosed a position in BTAI (BIOXCEL THERAPEUTICS INC) in their most recent 13F filing.
Who is the largest institutional holder of BTAI?: Izzy Englander, Millennium Management, holds the largest disclosed position in BTAI, valued at $3M.
Did institutional ownership of BTAI increase or decrease?: Across recent 13F filings, tracked investors recorded 4 new positions, 0 increased, 0 reduced, and 0 fully exited BTAI.
Where does this BTAI ownership data come from?: SEC Form 13F-HR filings, accessed via EDGAR. 13F filings are disclosed quarterly with a 45-day reporting delay and cover U.S.-listed long equity positions only. This is not investment advice.